Arca Biopharma | ABIO - Собственный капитал и резервы





Собственный капитал и резервы Изменить Дата
Alterity Therapeutics Limited AUD 36.21M 18.58M 2025-12
Amgen USD 9.19B 532M 2026-03
Arca Biopharma USD 486.72M 17.72M 2026-03
Biogen USD 18.65B 394.9M 2026-03
Brainstorm Cell Therapeutics USD -11.01M 1.02M 2026-03
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Capricor Therapeutics USD 278.7M 27.09M 2026-03
Cipla INR 344.32B 15.13B 2026-03
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 102.73M 58.9M 2025-12
CSL USD 18.66B 2.75B 2025-12
Cytokinetics USD -826.57M 166.94M 2026-03
Daiichi Sankyo JPY 1.71T 57.86B 2025-12
Gilead Sciences USD 23.52B 897M 2026-03
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
Grifols EUR 6.21B 133.12M 2025-12
Laboratory Of America USD 8.73B 108.8M 2026-03
Myriad Genetics USD 337.4M 30.6M 2026-03
Otsuka Holdings JPY 3.11T 74.63B 2026-03
Pfizer USD 90.1B 3.63B 2026-03
United Therapeutics USD 5.9B 1.2B 2026-03